Swedish biotech company to give Scandion Oncology a foothold within immuno-oncology
![Nils Brünner, co-founder and CEO of Scandion Oncology | Foto: Scandion Oncology](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12200091.ece/ALTERNATES/schema-16_9/doc78ttzohghup10ecj8dau.jpg)
Copenhagen-based biotech company Scandion Oncology is attempting to increase the potential market for its key candidate, SCO-101.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.